{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Is Anuh Pharma technically bullish or bearish?
As of December 2, 2025, Anuh Pharma's trend has shifted to a bearish stance with moderate strength, driven by bearish MACD and moving averages, alongside mixed signals from Bollinger Bands and KST, indicating a negative outlook for the stock.
Anuh Pharma Technical Momentum Shifts Amid Mixed Market Signals
Anuh Pharma, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals across various timeframes. Recent evaluation adjustments highlight a transition in the stock’s technical trend, prompting a closer examination of its price action and indicator readings amid broader market conditions.
Anuh Pharma’s Market Assessment Shifts Amid Mixed Financial and Technical Signals
Anuh Pharma has experienced a revision in its market evaluation following a complex interplay of financial performance, valuation metrics, and technical indicators. Despite recent quarterly setbacks and underperformance relative to broader indices, subtle shifts in technical trends and promoter activity have influenced the company’s overall market assessment.
Anuh Pharma Technical Momentum Shifts Amid Mixed Market Signals
Anuh Pharma, a player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of market forces. Recent price movements and technical indicators reveal a nuanced picture of the stock’s near-term trajectory, with mixed signals from key momentum and trend-following tools.
How has been the historical performance of Anuh Pharma?
Anuh Pharma has shown consistent growth in net sales, increasing from 306.96 Cr in Mar'20 to 661.51 Cr in Mar'25, despite recent declines in profitability metrics. Total assets also grew significantly, while cash flow from operating activities improved notably in the same period.
Why is Anuh Pharma falling/rising?
On 25-Nov, Anuh Pharma Ltd’s stock price continued its downward trajectory, closing at ₹77.07, down by ₹0.42 or 0.54%. This decline reflects a sustained period of underperformance relative to both its sector and the broader market benchmarks.
Anuh Pharma Faces Significant Selling Pressure with 27.42% Year-to-Date Loss Amid Poor Performance
Anuh Pharma Ltd is experiencing notable selling pressure, continuing a trend of losses. The stock has declined significantly over various time frames, contrasting sharply with the Sensex's performance. Factors contributing to this trend include underperformance relative to its sector and trading below key moving averages.
How has been the historical performance of Anuh Pharma?
Anuh Pharma has demonstrated steady growth in net sales, increasing from 486.65 Cr in Mar'22 to 661.51 Cr in Mar'25, but faced challenges in profitability, with profit metrics declining from Mar'24 to Mar'25 despite improved cash flow. Total assets also grew significantly during this period.
Anuh Pharma Faces Technical Shift Amidst Declining Stock Performance and Rising Promoter Confidence
Anuh Pharma, a microcap in the Pharmaceuticals & Biotechnology sector, has experienced a recent evaluation adjustment, indicating a shift in its technical outlook. The company has faced performance challenges, including a notable year-to-date decline, while promoter confidence appears to be rising with increased stakeholder holdings.
Is Anuh Pharma technically bullish or bearish?
As of November 10, 2025, Anuh Pharma's technical trend has shifted to bearish, supported by negative signals from the MACD, Bollinger Bands, and moving averages, indicating a lack of strength for any potential recovery.
Anuh Pharma Faces Bearish Technical Trends Amid Market Volatility and Mixed Performance
Anuh Pharma, a microcap in the Pharmaceuticals and Biotechnology sector, has experienced recent stock price fluctuations, currently at 81.49. The company shows bearish technical indicators and has underperformed the Sensex in the short term, though it has outperformed over the past three years, reflecting mixed market dynamics.
Why is Anuh Pharma falling/rising?
As of 10-Nov, Anuh Pharma Ltd's stock is priced at Rs 81.49, down 5.23%, and has underperformed its sector significantly. The stock is in a bearish trend, trading below key moving averages, with declining delivery volume and a year-to-date drop of 27.81%, indicating substantial challenges in the current market.
How has been the historical performance of Anuh Pharma?
Anuh Pharma has shown steady growth in net sales, increasing from 306.96 Cr in Mar'20 to 661.51 Cr in Mar'25, while profitability metrics have fluctuated, with profit after tax decreasing from 60.06 Cr in Mar'24 to 47.35 Cr in Mar'25. Total assets rose from 326.37 Cr to 504.55 Cr during the same period, indicating overall growth despite some volatility in profits.
Are Anuh Pharma latest results good or bad?
Anuh Pharma's latest results show strong revenue growth of 22.54% to ₹372.36 crores, but net profit fell 35.19% to ₹15.91 crores, indicating significant margin pressure and operational challenges that raise concerns about profitability sustainability.
Anuh Pharma Q2 FY26: Profit Decline Amid Revenue Growth Raises Margin Concerns
Anuh Pharma Ltd., a leading manufacturer of Active Pharmaceutical Ingredients (APIs) specialising in antibiotics and bulk drugs, finds itself navigating turbulent waters as its stock trades at ₹85.45, down 14.12% over the past year and significantly below its 52-week high of ₹121.00. With a market capitalisation of ₹856.00 crores, the micro-cap pharmaceutical company has delivered a mixed performance in FY2025, posting annual revenue of ₹661.00 crores—a modest 2.2% year-on-year growth—whilst net profit declined sharply to ₹47.00 crores from ₹60.00 crores in FY2024, representing a concerning 21.67% contraction.
How has been the historical performance of Anuh Pharma?
Anuh Pharma has demonstrated consistent growth in net sales and total assets, increasing from INR 486.65 crore in March 2022 to INR 661.51 crore in March 2025. However, profitability metrics have declined, with profit after tax falling from INR 60.06 crore to INR 47.35 crore during the same period.
Anuh Pharma Experiences Mixed Financial Performance Amid Rising Promoter Confidence
Anuh Pharma has recently experienced a change in its evaluation, reflecting a shift in technical indicators. The company's financial performance shows mixed results, with a modest operating profit growth and a decline in profit after tax. However, it maintains a low debt-to-equity ratio and rising promoter confidence.
Anuh Pharma Experiences Technical Trend Shifts Amidst Market Volatility and Performance Variability
Anuh Pharma, a microcap in the Pharmaceuticals and Biotechnology sector, has seen notable stock price movements and significant volatility over the past year. Despite a recent strong weekly performance, its year-to-date results show a decline, contrasting with the broader market's gains, while long-term returns remain robust.
Why is Anuh Pharma falling/rising?
As of 24-Oct, Anuh Pharma Ltd's stock price is Rs 87.15, up 4.37% with a total return of 10.55% over the last six days. Despite recent gains and increased investor interest, the stock has declined 22.79% year-to-date, underperforming compared to the benchmark Sensex.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
